Common autoimmune drug shown to help patients with giant cell arteritis
A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant cell arteritis, […]
A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant cell arteritis, […]
At the surface, the immune response to a flu virus is simple. Some cells recognize the pathogen and send a
Volume 54, Issue 4, July 2025, Page 302-310.
Volume 54, Issue 4, July 2025, Page 242-251.
Volume 54, Issue 4, July 2025, Page 292-301.
Volume 54, Issue 4, July 2025, Page 263-271.
Volume 54, Issue 4, July 2025, Page 272-281.
Volume 54, Issue 4, July 2025, Page 314-315.
Volume 54, Issue 4, July 2025, Page 252-262.
Volume 54, Issue 4, July 2025, Page 316-318.
Healio Clinical Guidance announced the launch of Drug Lookup, a free tool that provides fast, reliable access to drug monographs
OBJECTIVE: Nerve growth factor (NGF) and glial cell line-derived neurotrophic factor (GDNF) are proteins that support the growth and survival
OBJECTIVE: This study aimed to evaluate the association between tumor necrosis factor-α inhibitor (TNFi) therapy and cardiovascular (CV) outcomes, as
OBJECTIVE: The immune system of the body mistakenly targets its own joints in rheumatoid arthritis (RA), a chronic autoimmune disease
Osteoarthritis (OA) is a chronic and progressive degenerative disease that affects joint structures, such as the hips, knees, and hands,
OBJECTIVE: In our study, we analyzed the efficacy and safety data of patients with systemic lupus erythematosus (SLE) after switching
OBJECTIVE: This study aimed to evaluate the efficacy and safety of total glucosides of paeony (TGP) in patients with primary
OBJECTIVE: Multicause-of-death methods were used to analyze mortality and leading causes of death associated with polymyalgia rheumatica (PMR) in the
OBJECTIVE: Behçet’s disease etiology is uncertain, and no specific diagnostic markers exist in the laboratory. This retrospective study aimed to
OBJECTIVE: This study aimed to describe the clinical spectrum of primary Sjögren’s syndrome (pSS) patients with anti-Ro/SS-A and anti-La/SS-B negativity.
OBJECTIVE: Pulmonary arterial hypertension (PAH) represents an important vascular complication of mixed connective tissue disease (MCTD) and systemic sclerosis (SSc).
Despite obesity’s well-known influence on AF recurrence, neither comorbidity has a significant influence on outcomes from early rhythm control therapy.
FDA grants Fast Track to NRX-100, the first preservative-free IV ketamine, for treating suicidal ideation in depression.
After overcoming 2 FDA rejections, PharmaTher secures approval for ketamine (KETARX) in surgical pain.
At the recent Association of Women in Rheumatology annual conference, AWIR and ACR leaders discussed advocacy’s important role in supporting